Contact
Start a Conversation
If you are evaluating commercialization strategy for a diagnostic platform, preparing for U.S. market entry, or assessing adoption risk prior to a major milestone, we welcome an introductory discussion.
30 minute diagnostic conversation to identify the most critical commercialization risk in your current plan.
Typical Conversations
AdvisoryDx works with diagnostic founders, investors, and leadership teams navigating key commercialization decisions, including:
- Preparing a diagnostic platform for U.S. market entry
- Aligning clinical evidence with reimbursement strategy
- Evaluating commercialization readiness prior to regulatory submission
- Designing distribution or channel strategy
- Assessing adoption risk before fundraising or launch
Prefer to schedule directly? Book a call above. Want to tell us about your platform first? Use the form below.
Send a Message
We typically respond within one business day.
Direct Contact
Mailing Address
7901 4th St N
Suite 300
St. Petersburg, FL 33702
All conversations are confidential. AdvisoryDx does not share company information with third parties.